Brock String Therapy for Concussion
Trial Summary
What is the purpose of this trial?
The purpose of the proposed study is to evaluate the efficacy of Brock String therapy prescribed in the acute stage of concussion recovery can improve clinical outcomes among patients with receded near point of convergence (NPC). Aim 1: Determine if participants receiving the Brock String have more significant improvements in NPC measurements at follow up 7-10 days post injury. Aim 2: Determine if participants receiving the Brock String 1) improve on computerized neurocognitive test scores from initial visit (\<48 hours post injury) to follow up visit (7-10 days post injury) compared to control participants, and 2) have reduced recovery time (i.e., days from injury until return to play) compared to control participants.
Research Team
Anthony P Kontos, PhD
Principal Investigator
University of Pittsburgh
Alicia Trbovich, PhD
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for athletes aged 12-20 who have had a concussion during organized sports in the last 48 hours and show a receded near point of convergence (NPC) greater than 10 centimeters. It's not suitable for those without smartphone access, with severe symptoms, recent concussions, vestibular or seizure disorders, significant brain injury history, intellectual disabilities, or substance abuse issues.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Assessment
Participants receive initial assessment and instruction on Brock String therapy or standard of care
Treatment
Participants perform Brock String therapy at home twice daily or receive standard of care
Follow-up
Participants are monitored for improvements in NPC measurements and neurocognitive test scores
Extended Follow-up
Participants are monitored for concussion recovery duration until return to play
Treatment Details
Interventions
- Brock String Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor